Eli Lilly aims for a new high after launching DTC service for weight-loss drugs. Cramer says let it ride

The latest catalyst for Eli Lilly is a corporate decision more common in the retail and entertainment industries, not pharmaceuticals.

from US Top News and Analysis https://ift.tt/n3d9wAu
https://ift.tt/3R2XBCp